MétaCan
Menu
Back to cohort
Record W4411437072 · doi:10.1016/j.jtct.2025.06.015

Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy

2025· article· en· W4411437072 on OpenAlexaff
Niketa C. Shah, Alexander Ngwube, Tara Suresh, Anna Sowa, Allistair Abraham, Eric Anderson, Martin Andreánsky, Monica Bhatia, Sonali Chaudhury, Geoff D.E. Cuvelier, Jignesh Dalal, Michael Grimley, David A. Jacobsohn, Naynesh Kamani, Jennifer Krajewski, Lakshmanan Krishnamurti, Shermini Saini, Jodi Skiles, Shalini Shenoy

Bibliographic record

VenueTransplantation and Cellular Therapy · 2025
Typearticle
Languageen
FieldMedicine
TopicHematopoietic Stem Cell Transplantation
Canadian institutionsChildren's Hospital Research Institute of Manitoba
FundersChildren's Discovery Institute
KeywordsMedicineAbataceptPrednisoneInternal medicineTransplantationHematopoietic stem cell transplantationGraft-versus-host diseaseRituximabSurgeryImmunologyLymphoma

Abstract

fetched live from OpenAlex

Allogeneic hematopoietic cell transplantation (HCT) provides a curative option for patients with hemoglobinopathies by establishing donor-derived hematopoiesis. However, outcomes are compromised by toxicities and graft-versus-host disease (GVHD), particularly in patients older than 13 years undergoing HCT from unrelated donors. To evaluate the safety and benefit of extended duration (until day +365) abatacept incorporated into GVHD prophylaxis compared to standard prophylaxis that included prednisone in children and adolescents with hemoglobinopathy undergoing HCT from related and unrelated donors. Forty patients with hemoglobinopathy received reduced intensity conditioning and prednisone-inclusive GVHD prophylaxis. Donors were matched siblings or matched/mismatched unrelated donors. Outcomes were compared with 20 subsequent patients who received extended duration abatacept instead of prednisone and targeted lower tacrolimus levels. The incidence of posterior reversible encephalopathy syndrome (PRES) was 17% with prednisone and 0% with abatacept. Acute grade 3 to 4 GVHD occurred in 28% of patients who received prednisone and in 0% that received abatacept (P = .011). Among patients who received prednisone, chronic GVHD (cGVHD) was observed in 2.5% (mild), 5% (moderate), and 30% (severe) of cases. In contrast, abatacept recipients experienced cGVHD at rates of 25% (mild), 5% (moderate), and 5% (severe). Skin/oral involvement was most common in patients with cGVHD who received abatacept. Post-transplant immune reconstitution patterns were similar in both groups. Infection in the presence of GVHD and systemic immune suppression intensification was the primary cause of mortality in patients who received prednisone. The only death in the abatacept group was a patient with primary graft rejection that died after a subsequent transplant. Two patients in the abatacept group developed EBV-associated lymphadenopathy that responded to rituximab. Overall survival and event-free survival were 87% and 80% with prednisone. The corresponding numbers were 95% and 90%, respectively, with abatacept, despite a higher proportion of recipients at risk for poor outcomes (older age, mismatched grafts) in the abatacept group. Including extended duration abatacept and eliminating prednisone as GVHD prophylaxis was safe, effective in eliminating PRES, and reducing the incidence and severity of acute and cGVHD in children, yielding similar outcomes after matched sibling and unrelated donor HCT.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.240
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.281
Teacher spread0.269 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations7
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueTransplantation and Cellular TherapySame topicHematopoietic Stem Cell TransplantationFrench-language works237,207